Cutaneous Oncology News

After Mohs micrographic surgery, patients report adequate pain control in 97% of all 8-hour increments based on pain diary results, indicating appropriate pain management overall after surgery, according to findings published in Journal of the American Academy of Dermatology.

The rates of melanoma, the deadliest form of skin cancer, are increasing exponentially, with research presented at the American Academy of Dermatology Summer Meeting reporting an 800% increase between 1970 and 2009 among women aged 18 to 39 years.

Antibiotics administered to treat Staphylococcus aureus appeared to inhibit disease activity among patients with advanced cutaneous T-cell lymphoma, according to results of a prospective study published in Blood.

Application density for aerosol sunscreen is higher than that of lotion in practical use, according to a cross-sectional study.

The Parker Institute for Cancer Immunotherapy, in collaboration with the Juvenile Diabetes Research Foundation and Helmsley Charitable Trust, have formed a cancer and diabetes research initiative to better understand the association between immunotherapy treatment and subsequent risk for type 1 diabetes.

NCI awarded a 5-year, $11 million grant to NYU Langone Health’s Ronald O. Perelman department of dermatology to develop biomarkers that can predict whether immunotherapy will be effective for specific patients.

There is a small but statistically significant increased risk for cancer in patients with psoriasis, which is mainly driven by lymphoma and nonmelanoma skin cancer, Megan H. Noe, MD, MPH, MSCE, of the department of dermatology at Brigham & Women’s Hospital in Boston, said in an interview with Healio Dermatology.

Increased intake of dietary vitamin A decreases the risk of incident squamous cell carcinoma, according to a large, prospective study.

The FDA granted breakthrough therapy designation to bempegaldesleukin in combination with nivolumab for initial treatment of unresectable or metastatic melanoma.

NEW YORK — While new drugs for cancer are helping patients fight the disease, they also produce side effects that can affect the hair, skin and nails and can significantly affect quality of life and, potentially, the ability to continue treatment, according to a press release issued here at the American Academy of Dermatology Summer Meeting.